Trutrace Technologies Inc. (TTTSF)

[garrettf]

It's interesting. I follow Rob and I see who he follows and his likes. He generally follows people and begins to like their stuff after working with them. So I'm trying to do some form of an experiment- see who he follows today and see if any news comes out tomorrow for a new partner, etc. Not that it works by any means but he followed about 10 new people recently and the news came out about the health effects of marijuana study with all those new followers involved.

Will keep everyone updated if I see anything new come along.

[aries4747]

More active on Twitter, too.

https://twitter.com/TruTraceTech

[aries4747]

Looks like MM's positioning themselves for run. I noticed that earlier but didn't see the news til now.

[aries4747]

TruTrace Technologies Update

2:00 PM ET 7/14/20 | Dow Jones
TruTrace Technologies Update

July 14, 2020 -- (TruTrace Technologies) --

(TheNewswire)July 14, 2020 - TheNewswire - TruTrace Technologies (CNSX:TTT.CN), (OTC:TTTSF) would like to share the following from the desk of the CEO:

Friends:

I hope this letter finds you well and that you are staying safe during these unprecedented times. On behalf of the entire TruTrace Technologies team, I'd like to thank you for your ongoing support and commitment to our organization.

As you know, over the past two years we at TruTrace have been on a path to bring greater transparency and interoperability to the medical cannabis sector. Our mission is aimed squarely at delivering innovative technology to bring visibility and collaboration to this emerging industry. They say nothing worth having comes easy and further, if there is one word that defines every member of our team it is simply...resiliency.

Our resiliency has kept us on track, committed to deliver on time and under budget for our largest client, and our resiliency will never waiver.

Over the past few weeks, we're happy that we've been able to share some exciting news. From securing a strategic partnership with OrionOne Global, which aligns TruTrace with the global freight and logistics space, to a landmark moment for the company and the culmination of countless months of work.

On Thursday, July 9th, the largest health research organization in North America, University Health Network and Canada's largest pharmacy Shoppers Drug Martannounced the launch of a ground-breaking Real-World Evidence study underpinned by our blockchain technology.

Over a year in the making, this deployment represents the real-world implementation of our StrainSecure(TM) platform within the Shoppers ecosystem with an aim to become a fundamental part of legalized medical cannabis for years to come.

We are proud of our accomplishments and grateful to our client/partners at: Aphria, Aurora Cannabis, Avicanna, Inc., CanniMed, Dosecann Solutions, MediPharm Labs, Organigram, Radient Technologies, The Flowr Corporation The Valens Company, WeedMD Rx Inc./Starseed Medicinal Inc. and Zenabis Global, as well our laboratory partners at Sigma Analytical, Anandia Labs and High North.

This is our moment. This is our chance to dig deeper, stay committed to road ahead, stay resilient and continue on a path to achieving our goals.

From my desk to yours, I would like to thank you again for your support.

Best regards,

Robert Galarza

CEO

TruTrace Technologies, Inc.

(CSE: TTT / OTCQB: TTTSF)

[e-mail]

844-656-3629

Copyright (c) 2020 TheNewswire - All rights reserved.

> Dow Jones Newswires

July 14, 2020 14:00 ET (18:00 GMT)

[garrettf]

Yep does look good. They also have a posting for hiring an Intern now that I saw on another website.

Would like to see another updated investor document with a better plan. Old one from March but wondering how much has since changed. CEO has come alive now but besides an empty partnership with Orionone and a medical marijuana study with big players, not much has changed. Not sure what money the study brings into TTT right away, maybe it'll spur longer term growth though.

[garrettf]

https://www.globenewswire.com/news-release/2020/07/14/2061871/0/en/WeedMD-Cultivars-Included-in-UHN-led-Chronic-Pain-Study.html

[Bute]

I see where Trutrace has redone they're Web Home Page. It's a lot more professional looking. Not really a whole lot of information, but at least it's a better attitude and not so humdrum like the old page was.

[garrettf]

[garrettf]

Two pieces of news referencing Shoppers

https://ca.finance.yahoo.com/news/shoppers-drug-mart-aims-to-grow-medical-pot-sales-with-more-data-113255344.html

https://www.thechronicleherald.ca/news/canada/new-study-to-examine-efficacy-of-medical-cannabis-bring-standardization-to-cannabis-industry-471168/#.Xwc0kYv1k-0.twitter

[Bullkidz]

I bought this stock almost two years ago at 26 cents on a down spike. He was listed as co founder etc and after a little research, He was also co founder of Globatom, Heated details etc. You start connecting the dots after you see a pattern. At first glance story sounds great but then it's not hard to see what's going on after a while. I bought more at 2 cents on a flyer just in case something happens. But with this PR it looks like another typical shady deal. They don't have money to pay this clown so he gets paid in stock. Lets hope they the least they do is pump this up and we can get out and move on.

[garrettf]

So it looks like Tommy used to work there as the CTO per this article

https://www.geekwire.com/2016/shipping-simplifier-globatom-scores-new-investment-execs-goes-microsoft-azure/

But what's interesting is the old strainsecure investor deck says Tommy was a Cofounder of it which is false...

https://strainsecure.com/wp-content/uploads/2019/04/strainsecure-investor-overview-apr-12-2019.pdf

The Globatom website doesn't work anymore so I'm not sure what happened to it and there's no news for Globatom for a few years now. So where did you find that stuff out about Tommy?

[Bullkidz]

Is Orion One the old Globatom logistics company? Didn't this clown Tommy get money for Globatom in the past and spend it on strippers? What happened to that company? Is it now Orion One? I think you are 100% correct. Thes all seem to be Shady deals which is why never any transparency or revenue out of any of them. So 7.7 million shares for what a new website with no customers. Heated details takes all the money and also has 0 transparency as well. That's why They run no revenue through TTTSF. If they did why is it abandoned and trading at 3 cents

[Bute]

No, I can't head for the hills. I got too much invested in this company now to get out. I would lose almost all I have invested. I own 135,685 shares. So I'm like you, I will hang in there to see what happens down the road. I really thought this company would do much better than they have. Show's you what I know.

[garrettf]

It's just a licensing deal so far so that allows TTT to extend into other industries for logistics. Right now it's just a circle jerk between the cofounder, Tommy, and his companies- Orionone, Heated Details, and TTT. So we'll see if any deals come from it.

As far as running for the hills, chances are you already lost most of your investment considering it's gone from 18 cents to 3, so it's probably not worth selling now unless you want what little money you have left. I'm just holding my 30k shares for the long run to see if anything happens.

[garrettf]

Interview - https://ca.proactiveinvestors.com/companies/news/923421/trutrace-technologies-signs-software-deal-with-orionone-global-923421.html

Just like all interviews, positive attitude with little details.

[aries4747]

TruTrace Technologies Signs Software Licensing Agreement with Global Supply Chain and Logistics Software Provider OrionOne Global

9:21 AM ET 7/3/20 | Dow Jones
TruTrace Technologies Signs Software Licensing Agreement with Global Supply Chain and Logistics Software Provider OrionOne Global

July 03, 2020 -- (TruTrace Technologies) --

(TheNewswire)July 3, 2020 - TheNewswire -TruTrace Technologies Inc. (CSE:TTT); (CNSX:TTT.CN); (OTC:TTTSF) ("TruTrace" or the "Company"), creator of a fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, is pleased to announce it has signed a software license agreement with OrionOne Global, Inc. ("OrionOne"), a global supply chain provider delivering best-in-class technology which serves as a logistics and tracking smart-hub for navigating shipments and logistics worldwide.

Under the agreement (the "License Agreement"), TruTrace will be able to leverage the OrionOne platform to support commercialization of its core products for its customers. "Finalizing this license agreement with OrionOne not only assures the long-term functionality of StrainSecure(TM), but we believe it will open up market opportunites for TruTrace in other key industries," stated Robert Galarza, CEO of TruTrace. "Our core mission was built on traceability of quality assurance and testing details at a very granular level and we believe the incorporation of logistics tracking will significantly expand our client base."

"We are thrilled to bring together these synergetic technologies. Licensing OrionOne will give TruTrace the ability to maximize its commercial opportunites, as well as begin to expand its offering beyond the cannabis industry," said Tommy Stephenson, Founder and CEO of OrionOne. "When we developed OrionOne over four years ago it was done so with a macro view of shipping and logistics which will compliment the precise level of detail provided by TruTrace incredibly well."

About TruTrace Technologies

TruTrace Technologies is the developer of fully integrated software, secured on a blockchain infrastructure, that gives clients the ability to store, manage, share and immediately access quality assurance and testing details, COAs, as well as motion and movement intelligence on inventory from batches and lots to serialized items.

The platform was specifically designed to power the traceability of testing standards within the legal cannabis, nutraceutical, food and pharmaceutical space with a focus on the authentication of source materials or ingredients used in formulation.

Highlights of the system include:- Interoperable and collaborative - Master registry for source ingredients - Data secured and immutable - API integrations to 3rd party systems for record management, reporting and e-commerce - Real-time testing details connected to each inventory item - Master testing dashboard for manufacturers and laboratories, including financials - Digital management of LOD (Limits of Detection) and LOQ (Limits of Quantification) to power transparent testing - Dynamic batch/lot management

- Quality assurance specs and threshold alert capabilities

Under the License Agreement, the Company has agreed to pay OrionOne, a company controlled by an officer of the Company, Tommy Stephenson, an initial license fee of CAD $385,000 which shall be paid through the issuance of 7,700,000 common shares of the Company (each, a "Common Share") at a deemed price of $0.05 per Common Share to OrionOne. The initial term of the License Agreement is five years, renewable for consecutive five year terms with the license being perpetual in nature. In addition, the Company agreed to pay OrionOne a fee of US$25,000 within 30 days of the closing of the Company's next equity financing, or six months from the date of the License Agreement, whichever is sooner. The Company also agreed to pay OrionOne a nominal annual license fee in lieu of royalty payments.

The Common Shares issued in connection with the License Agreement are subject to resale restrictions imposed by applicable law or regulation, including a statutory hold period expiring November 3, 2020.

The License Agreement with OrionOne (the "License") was a "related party transaction" within the meaning of Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The License was exempt from the valuation requirement of MI 61-101 by virtue of the exemptions contained in section 5.5(b) of MI 61-101 as the Company's Common Shares are not listed on a specified market and from the minority shareholder approval requirements of MI 61-101 by virtue of the exemption contained in section 5.7(1)(b) of MI 61-101 in that the fair market value of the License did not exceed $2,500,000 and the other conditions set out in section 5.7(1)(b) of MI 61-101 were met. As the material change report disclosing the License is being filed less than 21 days before the transaction, there is a requirement under MI 61-101 to explain why the shorter period was reasonable or necessary in the circumstances. In the view of the Company it was necessary to immediately close the Licenes and therefore, such shorter period was reasonable and necessary in the circumstances to secure valueable rights for the Company.


For More Information:

Robert Galarza, Chief Executive Officer and Director, 844-656-3629

Disclaimer for Forward-Looking Information

This news release contains forward-looking information that involves various risks and uncertainties regarding future events. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company, such as statements that TruTrace will be able to leverage the OrionOne platform to support commercialization of its core products, and the companies will work together to discover mutually beneficial opportunities in markets around the world;the License Agreement assures the long-term functionality of StrainSecure(TM),the Company's hopes that it will open up market opportunites for TruTrace in other key markets;the Company's belief that linking into global freight will significantly expand its client base; and that licensing OrionOne will give TruTrace the ability to maximize its commercial opportunites, as well as begin to expand its offering beyond the cannabis industry. There are numerous risks and uncertainties that could cause actual results and the Company's plans and objectives to differ materially from those expressed in the forward-looking information, including adverse market conditions and other factors beyond the Company's control. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. The Company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Copyright (c) 2020 TheNewswire - All rights reserved.

> Dow Jones Newswires

July 03, 2020 09:21 ET (13:21 GMT)

[Bute]

So what is the bottom line here? I can't make out most of the post. So should we run to the hills or what?

[garrettf]

June 26,
“Compan
intellectu
indebted
vendor r
proprieta
intellectu
Pursuant
9,500,000
per Com
$0.05 per
assignee
Common
concurre
the Comp
“With th
high, it b
that the c
willingne
to our vis
The Com
applicabl
The Debt
transactio
Security
from the
5.5(b) of
from the
contained
did not e
met. As t
days befo
period w
uTrace Tec
2020. TruT
ny”), creato
ual property
dness (the “In
responsible
ary StrainSe
ual property
t to the settl
0 common sh
mmon Share
r Common S
of HD. Th
n Shares to
ent to the De
pany.
he changes in
became impe
commitmen
ess and desi
sion and glo
mmon Shares
le law or reg
t Settlement
on” within
Holders in
e valuation r
MI 61-101 a
minority sh
d in section
exceed $2,50
the material
ore the tran
was reasonab
chnologie
Secure
Trace Techn
or of a ful
y for the ca
ndebtednes
for softwar
ecure™ pla
.
lement of th
hares of the C
to an assign
Share to an o
he Compan
preserve ca
ebt Settleme
n the global
erative for T
nt of its key t
re of Heated
obal opportu
s issued in th
gulation, inc
t with Thom
the meanin
Special Tra
requirement
as the Comp
hareholder a
5.7(1)(b) of
0,000 and th
l change rep
saction, ther
ble or neces
es Annou
Rights to
nologies Inc
lly-integrate
annabis indu
ss”) previous
re developm
atform, ther
he Indebtedn
Company (e
nee of HD a
officer of the
y chose to
ash and imp
ent, HD has
market, and
TruTrace to
technology p
d Details to i
unity.
he Debt Sett
luding a sta
mas Stephens
ng of Mult
ansactions (
of MI 61-10
pany’s Comm
approval req
MI 61-101 in
he other con
port disclosin
re is a requir
sary in the
unces Shar
o Intellect
c. (CSE: TTT
d blockcha
ustry, today
sly owed to
ment, design
reby securin
ness (the “D
each, a “Com
and 9,500,000
e Company,
settle the
prove the C
agreed to a
d the desire
secure right
partner” sta
invest into th
tlement are
tutory hold
son (the “Of
tilateral Inst
“MI 61-101
01 by virtue
mon Shares
quirements o
n that the fai
ditions set o
ng the Offic
rement und
circumstanc
res for De
tual Prop
T; OTCQB:
in platform
y announced
Heated Deta
n and main
ng valuable
Debt Settlem
mmon Share
0 Common
Thomas Ste
Indebtednes
Company’s
advance cred
for trust and
ts to its intel
ated TruTrac
he future of
subject to re
period expir
fficer Settle
trument 61-
”). The Offi
e of the exem
are not liste
of MI 61-101
ir market va
out in section
cer Settleme
der MI 61-10
ces. In the v
ebt Trans
perty
TTTSF) (“T
m that regis
d it has set
ails, Inc. (“H
ntentance of
e rights to
ment”), the
e”) at a deem
Shares at a
ephenson, w
ss through
balance she
dit for addit
d transparen
llectual prop
ce CEO Rob
our Compa
esale restrict
ring October
ement”) was
-101 Protect
icer Settlem
mptions con
ed on a spec
1 by virtue o
alue of the O
n 5.7(1)(b) o
nt is being f
1 to explain
view of the
sactions to
TruTrace” o
sters and t
ttled $950,0
HD”) the pri
f the Comp
the Comp
Company is
med price of
deemed pri
who was a se
the issuanc
eet. Furtherm
tional servic
ncy at an all
perty and en
bert Galarza
any is a testa
tions impose
r 27, 2020.
s a “related p
tion of Min
ment was ex
ntained in se
cified marke
of the exem
Officer Settle
of MI 61-101
filed less tha
n why the sh
Company it
o
or the
tracks
00 of
mary
any’s
any’s
ssued
$0.05
ice of
econd
ce of
more,
ces to
l time
nsure
“The
ament
ed by
party
nority
xempt
ection
t and
ption
ement
were
an 21
horter
t was
necessary to immediately close the Officer Settlement and therefore, such shorter period was
reasonable and necessary in the circumstances to improve the Company’s financial position.

[garrettf]

[Bute]

Someone is manipulating this stock big time. Draining it dry as much as they can. Makes me wonder who it could be. I have my thoughts on that subject. But more important is why? Why not let it go to see where it goes.

[garrettf]

https://sedar.com/search/search_form_pc_en.htm

Search for Trutrace.

Good question. I think there's still a need and still has a chance to be a good company. They might just be ahead of their time a little bit. I think they can make it through considering their Accounts Payable is with a related party (the founder's other company) and can just wait out the storm probably if Shoppers keeps paying.

[Bute]

Where? I haven't found the report. If they are that bad, that explains a lot. I don't understand, I thought this company had a good chance at making it a good company. What went wrong?

[garrettf]

Pretty poor financials released friday. Thoughts from anyone?

[garrettf]

https://www.proactiveinvestors.com/companies/news/914646/trutrace-technologies-welcomes-experienced-entrepreneur-cesare-fazari-as-director-914646.html

[JimDale]

Great stuff... bringing TruTrace along for the ride.

[garrettf]

#163 Strainprint CEO Andrew Muroff - Full Interview

Talks about trutrace at 7 minutes, then talks about it for 7 minutes plus. Also drops a golden egg at 15:10

[JimDale]

Then you should bail. They don't need to pump up the stock. I knew what I was buying into at $0.055. If the price was at $0.50 you'd be complaining that it was too high.

The current price is more than fair based their QoQ revs. Their market cap is $4.5million, and their run rate based on last QR, is $1.2 million, which put them at a 4:1 ratio. Factor in debt load and COGS, it's closer to 12:1, which is close to average for the sector.

As of right now, you actually have a ton of buying power. If these partnerships start proving themselves out, you'll lose that power because the price will skyrocket, and you know that. So, use this interval to accrue as many shares as you can, trade a small percentage to add to your core holdings and stop complaining about a gift.

[Bute]

A stock price of 0.055 is unacceptable for this stock. Do they want this company to succeed or not? This stock would be up around 0.50 if they would just release a few press releases. Say something positive, talk about a positive future, try to do something to help the investors here. I'm ready to bail on this one.

[JimDale]

Looks like the end of march.

Q3 ends 1/31, so they have 60 days to report.

Fiscal year ends April 30, so that report should be released ~7/31.

Q1 ends 7/31-report should drop ~9/30

Q2 ends 10/31-report should drop ~12/31

This is all based on past disclosure release dates.

[Bute]

When are earnings due?

[JimDale]

Tried to short a few shares. No Go. Market makers are holding this thing tight to the chest.

Saw where Galarza sold 500,000 shares recently. I'm assuming they're going into the black out period before Earnings. I'm sure he wishes the price were considerably higher....

[JimDale]

Quick partnership update on new partner:

http://cannabisproonline.com/news/trutrace-and-strainprint-to-collaborate-on-technology-to-drive-transparency-and-safety-for-consumers-and-cannabis-industry-stakeholders/

[Bute]

I totally agree. The information department for this company leaves a lot to be desired. I think the volume would increase ten fold if a little more information was available. This company could say a lot if they just would.

[JimDale]

It would be nice if the company was a little more proactive is information sharing. Maybe the sparseness in PR's is by design. Either way, there's not a lot of daily volume on this company.

[Bute]

https://www.proactiveinvestors.com/companies/news/910752/trutraces-blockchain-secured-cannabis-tracking-technology-sees-strong-adoption-910752.html

[aries4747]

How Pharma will soon use Blockchain to track your drugs.

https://www.computerworld.com/article/3439843/how-pharma-will-soon-use-blockchain-to-track-your-drugs.html

[aries4747]

TTTSF (.083): TruTrace Technologies Provides Corporate Strategy Update

7:00 AM ET 1/14/20 | Dow Jones
January 14, 2020 -- (TruTrace Technologies) --

(TheNewswire)Company plans to build on proven successes with entry into international markets, pharmaceutical and nutraceutical verticals

Toronto - TheNewswire -January 14, 2020 - TruTrace Technologies Inc. (CNSX:TTT.CN) (OTC:TTTSF) ("TruTrace" or the "Company"), creator of a fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, today provided an updated outlook for its corporate strategy and priorities for 2020. Highlights include a targeted expansion of the Company's StrainSecuretm traceability platform into the pharmaceutical and nutraceutical verticals, as well as entry into several international markets.

"The success of the medical cannabis verification pilot program has been tremendously important for us. It has validated our technology and begun to establish the StrainSecure platform as a potential de facto standard for quality assurance and traceability in the Canadian cannabis industry," said TruTrace Technologies CEO Robert Galarza. "We are currently focused and investing additional resources on transition of our platform into a fully operational ecosystem that could provide a revenue stream and in turn enable us to achieve cash-flow positive operations by the end of calendar year 2020, while also allowing us to pursue other exciting opportunities."

Mr. Galarza continued: "The technology we initially deployed in the medical cannabis sector is highly applicable in other verticals such as pharmaceuticals, nutraceuticals and even food safety, where it is equally important to have complete transparency on the origin and authenticity of products. In the next year we are aiming to establish a foothold in these sectors, as well as extend our footprint in cannabis traceability into several markets outside of Canada."

Key Accomplishments in Calendar 2019

TruTrace made significant progress in the execution of its business plan in 2019, highlighted by the following:

- By the close of 2019, TruTrace completed the first two phases of the medical cannabis verification pilot program (the "Pilot Program"), which is designed to increase transparency, interoperability and product identification within the medical cannabis industry.

- The first two phases of the Pilot Program also included the addition of several licensed producers and testing partners into the StrainSecure platform

. - Additionally, the development team enhanced the Company's technology, including meeting and incorporating the global traceability standards of GS1, furthering our partnership with Microsoft by utilizing their Azure solution for Canada, completing comprehensive modules to support laboratory management and dynamic quality assurance and finalizing APIs into several key technology partners. - Established relationships with customers and prospective partners in several international markets, as well as the pharmaceutical sector and the nutraceutical sector, with a view to ascertaining their unique needs and potentially adding them to the StrainSecure platform. - Finalized a strategic alliance with global giant Deloitte to combine TruTrace's technology with Deloitte's leadership in the cannabis space and to improve clients' ability to build trusted brands, ensure medical and recreational distributors and retailers receive accurate shipments, and provide consumers with confidence they are buying verified products from credible sources.

- Increased revenue and began to mitigate operational expenses as management was able to shift its focus from core product development to sales and account management.

Calendar 2020 Strategic Priorities

The Company's strategic priorities in 2020 include a planned expansion of its addressable market through the following initiatives:- Continue its execution of the StrainSecure medical cannabis traceability platform and advance the platform from POC to full operational implementation, thereby establishing a potential revenue stream to fund the Company's growth. - Deploy StrainSecure with an initial set of licensed producers in several rapidly growing international medical cannabis markets. - Advance several key strategic partnerships and alliances.

- Commencing business development initiatives with pharmaceutical and nutraceutical customers including utilization of the Company's traceability platform, adapted to meet specific requirements of these sectors.

The Company plans to provide updates throughout the year on the progress it makes towards achieving these strategic goals.

About TruTrace Technologies:

TruTrace Technologies has developed an integrated blockchain platform to register and track intellectual property in the cannabis industry. TruTrace's technology allows cannabis growers and breeders to identify and secure rights to their intellectual property. It also streamlines the administrative process and reduces the costs of genetic and mandatory quality-control testing for legal cannabis. TruTrace's technology is proprietary, immutable and cryptographically secure, thereby establishing an accurate and permanent account for cannabis strains from ownership to market.

For More Information:

Robert Galarza, Chief Executive Officer and Director, 844-656-3629. Investor Inquiries: Swapan Kakumanu, Chief Financial Officer, 844-656-3629, [e-mail]

Disclaimer for Forward-Looking Information

This news release includes forward-looking information within the meaning of Canadian securities legislation, concerning the business of TruTrace, including statements regarding:

the expansion of the Company's StrainSecuretm traceability platform into the pharmaceutical and nutraceutical verticals, as well as entry into several international markets, and the applicability of the Company's technology to those sectors; the Company's aims to establish a foothold in the pharmaceutical and nutraceutical sectors, as well as extend its footprint in cannabis traceability into several markets outside of Canada; the transition of the Company's platform from POC into a fully operational ecosystem that will allow the Company to pursue other exciting opportunities; the establishment of the StrainSecure platform as the de facto standard for quality assurance and traceability in the Canadian cannabis industry; the advancement of the Pilot Program to full operational implementation; the advancement of several key strategic partnerships and alliances; the commencement of business development initiatives with pharmaceutical and nutraceutical customers including utilization of the Company's traceability platform, adapted to meet specific requirements of these sectors; and the Company's plans to provide updates throughout the year on the progress it makes towards achieving these strategic goals.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that it will prove to be correct and actual results and future events could differ materially from those anticipated in such information. Forward-looking information necessarily involves known and unknown risks, including, without limitation, risks associated with: general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments in Canada, the United States, and elsewhere; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; and other risks beyond the Company's control. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties and other factors, many of which are beyond the control of the Company. Readers are cautioned not to place undue reliance on any forward-looking information contained in this news release. Forward-looking information contained in this news release is provided as of the date of this news release. The Company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

This news release contains future-oriented financial information and financial outlook information (collectively, "FOFI") about the Company, all of which are subject to the same assumptions, risk factors, limitations, and qualifications as set forth in the above paragraphs. FOFI contained in this news release was made as of the date of this news release and was provided for the purpose of providing further information about the Company's future business operations. The Company disclaims any intention or obligation to update or revise any FOFI contained in this news release, whether as a result of new information, future events or otherwise, except as required by law. Investors are cautioned that the FOFI contained in this news release should not be used for purposes other than for which it is disclosed herein.

Copyright (c) 2020 TheNewswire - All rights reserved.

> Dow Jones Newswires

January 14, 2020 07:00 ET (12:00 GMT)

[Bute]

https://www.proactiveinvestors.com/companies/news/910308/trutrace-technologies-ready-to-focus-attention-on-generating-revenue-in-2020-910308.html

[Bute]

This is just the tip of the iceberg. This company is still in it's infancy. I would venture to say a couple years down the road, this will be at least a $45.00 stock. It's exciting to be here and see all this take shape.

[aries4747]

Recent news for Akeso

https://www.prnewswire.com/news-releases/nxt-water-secures-golds-gym-so-cal-for-their-akeso-functional-fitness-water---along-with-their-exclusive-blockchain-backed-verification-qr-code-300969830.html


NXT Water Secures Gold's Gym So Cal for their AKESO Functional Fitness Water - Along with their Exclusive Blockchain Backed Verification QR Code

LAS VEGAS, Dec. 5, 2019 /PRNewswire/ -- NXT Water, the fastest growing entrant in the hemp-derived beverage space and the makers of Akeso, the ONLY 12mg Broad Spectrum, odorless, colorless, tasteless CBD water; continues to expand their growth in the Functional Beverage category. NXT Water has secured Gold's Gym Southern California as a strategic retail partner to carry Akeso Functional Fitness Water in the fitness capitol of the world.

NXT Water launched their cornerstone brand AKESO Functional Fitness Water in January to tremendous receptivity in the retail, fitness vertical. Akeso is also incorporating STRAINSECURE ® the developer of the first integrated blockchain platform that registers and tracks intellectual property for the cannabis industry – making Akeso the first-ever 100% fully verifiable food or beverage in the United States.


"My commitment is to provide every Gold's Gym member with the finest fitness experience possible," said Angel Banos, CEO of Gold's Gym Southern California. "Providing our members with on-premise access to groundbreaking products like Akeso is just another example of Gold's Gym forging new paths in personal fitness."

"We are truly excited about our relationship with Gold's Gym SoCal, the most iconic name in fitness," said Todd Waks CEO of NXT Water. "We believe that personal wellness is the #1 passion-point of every human being on the planet and hydration is its most essential component. Our water is built to assist people with their hydration and workout recovery to get them back in the gym without severe inflammation. In addition, we want every customer to know that Akeso has been tested by an approved, 3rd party Laboratory and that all of our results are 100% verifiable via our blockchain backed QR code prominently placed on each bottle," said Waks.

About NXT Water: Formed by seasoned executives from the beverage, entertainment and digital marketing verticals, NXT Water has created AKESO, the finest functional fitness water intended to significantly disrupt both the functional beverage industry as well as the burgeoning CBD industry projected to be over $20 Billion by 2024.
www.akesowater.com

About Gold's Gym: Gold's Gym claimed 691 clubs as of Dec. 31, 2018, 144 of which were corporate and 547 of which were franchised. The company is planning to open 30 franchised locations and enter the studio segment with group training concept Gold's Studio. www.goldsgymsocal.com

Disclaimer:
This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. There are no assurances for NXT Water. Although such forward-looking statements are based on management's reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances, except as required pursuant to applicable securities laws.

Media Contact:
Todd Waks
310-422-1537
[e-mail]

SOURCE NXT Water

[aries4747]

TTTSF's relationship with Shoppers Drug Mart could lead to pharmaceutical blockchain development, IMO.

"You are spot on. We founded TruTrace in the cannabis space because it was such an area of need and it is a space where innovation is being supported heavily. However, blockchain-enabled traceability which derives from testing data could work in any industry and we fully intend on exploring opportunities that are best suited for our software, albeit in due course, because we don’t want to spread ourselves too thin."

[aries4747]

Another highlight: "We are working with about ten major producers with several others getting finalized. Although our focus has been in Canada throughout year one, we’re seeing some exciting momentum in South America and the US as well.

[aries4747]

Liked this part. Wasn't aware of their relationship with NXT Water.

"... earlier this year we began working with NXT Water out of Los Angeles in the launch of their AKESO Hemp Derived Functional Fitness Water, which is in select stores and health clubs throughout Southern California. This relationship was actually born out of a blind test they performed on several leading CBD water products in the US market. They found most of the products fell well below the advertised amount of CBD, with some having none at all.

Alternatively, the AKESO product was consistently testing out at around 12 milligrams of broad-spectrum CBD per bottle and NXT wanted to find a way to communicate this to their customers. Hence, they turned to TruTrace and started using the StrainSecure platform. Today you can go into a market in California, pick up an AKESO, scan the verified StrainSecure QR code and see real-time testing data on the bottle you’re holding in your hand."

[garrettf]

Finally we get an interview. However, I'm not sure it said anything new? Only decent part that she should've asked more on:

Is TruTrace a pre-revenue company and if so, what do you hope to achieve five years down the line in terms of revenue, and new customers that adopt the StrainSecure platform?

As of today, we are no longer a pre-revenue company. Our platform is operating at both enterprise and grassroots levels and that is exciting because we scale at all levels in all markets.

As for our five-year projection, we fully intend on being a fundamental part of the growth of the medical cannabis industry worldwide, as well as playing a significant role on expanding the recreational market. The fact is that transparency and testing will never be circumvented in this industry and if we can be a fundamental part of that process and the market continues to scale as projected, we will be a unicorn.

[aries4747]

TTTSF:TruTrace’s blockchain-secured seed-to-sale cannabis tracking technology is a game-changer

https://www.proactiveinvestors.com/companies/news/909940/trutraces-blockchain-secured-seed-to-sale-cannabis-tracking-technology-is-a-game-changer-909940.html

Companies are flocking to the firm’s StrainSecure platform to track strains of medical cannabis and verify their authenticity
Trutrace Technologies Inc. - TruTrace’s blockchain-secured seed-to-sale cannabis tracking technology is a game-changer
CEO Robert Galarza says the firm’s platform streamlines the admin process, lowers costs related to genetic and quality-control testing for cannabis

TruTrace Technologies Inc (CSE:TTT) has developed the first blockchain-secured platform to track intellectual property for cannabis. It provides mandatory testing, DNA-based product validation, and product guarantees for patients and customers.

The Vancouver firm channels the power of blockchain to fix the grim realities of corrupted supply chains in the medical cannabis industry.

“It’s a combination of science, enterprise software, and blockchain technology,” said TruTrace Technologies CEO Robert Galarza. “By focusing on granular genetic, chemical and contaminant data, as well as motion and movement information and then merging that into a blockchain we are able to provide real-time data on each product being purchased.”

Galarza, a Renaissance man with tech credentials has a varied background. He’s been a corporate attorney, movie producer, advertising executive and entertainment lawyer. He’s even managed professional fighters and co-founded enterprise tech company Spark Digital Technologies.

WeedMD Inc (CVE:WMD) (OCTMKTS:WDDMF) and Harvest One Cannabis (CVE:HVT) (OTCMKTS:HRVOF) are big believers in TruTrace’s StrainSecure technology. WeedMD just saw 40 of its cannabis strains undergo validation as part of a pilot program. Other firms participating in the TruTrace and Shoppers Drug Mart medical cannabis verification pilot program include Aphria Inc (TSE:APHA), Aurora Cannabis Inc (TSE:ACB), The Flowr Corp, Tilray Canada Ltd (NASDAQ:TLRY), United Greeneries, and Zenabis Global.

The firm’s immutable, cryptographically secure technology is the brainchild of co-founder and chief technology officer Tommy Stephenson, who earlier developed enterprise software platforms for Microsoft and Mercedes Benz.

In an interview with Proactive, Galarza talked about how the firm’s technology could be a game-changer for the industry by tracking cannabis from seed-to-sale, providing quality assurance and real-time testing data.

What prompted you to use blockchain to track cannabis strains?

Great question. Our team has an extensive background in large enterprise software and data centric projects, as well as supply chain and logistics. In other words, at our core we are data nerds who happen to love cannabis, and understand the issues around moving this product around the world.

When blockchain came onto our radar a few years ago, we knew that it could be an incredibly powerful tool in data management. Combining this with the immutable recording nature of blockchain also made it attractive as a protection method for intellectual property and creating a permanent lineage for cannabis strains; thus, TruTrace was born.

My partner Tommy Stephenson has been developing some of the most phenomenal enterprise software platforms for companies like Microsoft, Mercedes Benz and even Major League Baseball for over two decades, and his passion and genius flows down into the team. Traveling to Seattle to visit the development shop is my favorite part of the job because there is almost a “Disney” feel to it. If we can dream it, our team can build it.

What can be done by cannabis producers to ensure customers trust what's in their weed?

It’s all comes down to transparency and product education. The conversation about who is the first in the world to cultivate a “strain” or who owns the rights to a particular “strain” is less important than the clear understanding that what I’m buying today is the same as what it was yesterday, or at least I’m told if it is slightly different. Cannabis producers are doing an amazing job cultivating a variety of products and we can help communicate all that great work to those down the supply chain.

Is TruTrace a pre-revenue company and if so, what do you hope to achieve five years down the line in terms of revenue, and new customers that adopt the StrainSecure platform?

As of today, we are no longer a pre-revenue company. Our platform is operating at both enterprise and grassroots levels and that is exciting because we scale at all levels in all markets.

As for our five-year projection, we fully intend on being a fundamental part of the growth of the medical cannabis industry worldwide, as well as playing a significant role on expanding the recreational market. The fact is that transparency and testing will never be circumvented in this industry and if we can be a fundamental part of that process and the market continues to scale as projected, we will be a unicorn.

WeedMD was your first customer, how many companies and cannabis producers are now on the StrainSecure platform?

We are working with about ten major producers with several others getting finalized. Although our focus has been in Canada throughout year one, we’re seeing some exciting momentum in South America and the US as well.

Would you describe TruTrace Technologies as a software company with a record-keeping system? Can your technology have applications in other industries?

You are spot on. We founded TruTrace in the cannabis space because it was such an area of need and it is a space where innovation is being supported heavily. However, blockchain-enabled traceability which derives from testing data could work in any industry and we fully intend on exploring opportunities that are best suited for our software, albeit in due course, because we don’t want to spread ourselves too thin.

Blockchain Technology Corp and TruTrace Technologies Inc are not the only companies you have founded. You are also the co-founder of Spark Digital Technologies. It seems you have a degree in law, but are a serial entrepreneur. What attracted you to the digital technology sector?

I have a pretty diverse background to say the least. I’ve worked in the marketing and traditional media industries, practised law, produced feature films, as well as a music and film festival, managed professional fighters and been a part of technology development in sports, video distribution, supply chain and now cannabis.

However, what drove me into digital technology was innovation, efficiency and imagination-based creation. When developing in this sector you can look at a problem, imagine how to resolve that problem and develop practical systems to resolve it. Truly, there is nothing more exhilarating than brainstorming on a whiteboard with Tommy and the team and a few months later seeing it come to life.

Can you talk about inflection points for TruTrace?

The biggest inflection point in my opinion has been our relationship with Shoppers Drug Mart and Loblaws. I’m not sure everyone fully grasps how much it means to have a company of their size, history and reputation in the medical cannabis industry.

Working alongside Shoppers changes the conversation about what our technology could mean for the industry because we are focusing on building a bridge between medical cannabis and the traditional medical industry, and that is a much larger divide than people like to discuss.

If we can help make cannabis a customary part of medical treatment, it could exponentially impact the trajectory of the industry in a positive way. The move brings medical cannabis closer in line with standards for other drugs.

What are your key markets and how do you expect them to shape up?

Right now, we are focusing on Canada the US and exploring some projects in Columbia and South America. With that being said, we are hearing amazing rumblings coming out of Europe for medical cannabis with traceability being a fundamental issue that needs to be resolved. All I can say is that the future is bright in all these markets.

Is it true that in California, TruTrace brought its StrainSecure technology to a cannabis water company by affixing QR codes on its bottles that customers can now scan to quickly learn about test results?

Yes, earlier this year we began working with NXT Water out of Los Angeles in the launch of their AKESO Hemp Derived Functional Fitness Water, which is in select stores and health clubs throughout Southern California. This relationship was actually born out of a blind test they performed on several leading CBD water products in the US market. They found most of the products fell well below the advertised amount of CBD, with some having none at all.

Alternatively, the AKESO product was consistently testing out at around 12 milligrams of broad-spectrum CBD per bottle and NXT wanted to find a way to communicate this to their customers. Hence, they turned to TruTrace and started using the StrainSecure platform. Today you can go into a market in California, pick up an AKESO, scan the verified StrainSecure QR code and see real-time testing data on the bottle you’re holding in your hand.

What are the hallmarks of an innovative company and does TruTrace Technologies fit the bill?

The hallmarks for an innovative technology company is adoption at various levels of industry. A great idea without customers unfortunately will remain nothing more than an idea. What you need is adoption at varying levels and a pedigree to meet the standards of Fortune 500 companies so you can capitalize on opportunities.

We believe TruTrace has achieved this in our young history. From Shoppers Drug Mart and Deloitte, to WeedMD and NXT Water, we’ve found great adoption at many levels and we truly believe that sets us up for long-term success.

Contact the author Uttara Choudhury at [e-mail]

Follow her on Twitter: @UttaraProactive

[aries4747]

TTTSF: Shoppers Drug Mart Expands Cannabis Sales Across Canada

https://grizzle.com/shoppers-drug-mart-expansion/

Martin Green
December 3, 2019
Marijuana Politics

Shoppers Drug Mart has expanded its online medical cannabis sales platform to cover five new Canadian provinces and territories.

The country’s largest drug store group today announced that it will now sell to patients in Newfoundland & Labrador, New Brunswick, Prince Edward Island, Manitoba, and Saskatchewan.

Shoppers Drug Mart is not permitted to sell medical cannabis at its 1,300 brick-and-mortar stores, but it commenced ecommerce sales in Ontario in January 2019. It then began selling medical cannabis in Alberta in April.

It has partnered with 12 licensed producers to secure medical cannabis products that it sells direct to patients via a dedicated section of its website, Medical Cannabis by Shoppers. Jeff Leger, president at Shoppers Drug Mart, said Canadian patients have been left behind by traditional retail models, arguing that they need more convenient access to medical marijuana.

“We expanded Medical Cannabis by Shoppers nationally to provide enhanced service to more patients so they can feel empowered to access medical cannabis through the medical market with the guidance of healthcare professionals,” he said.

The firm cited Statistics Canada data and said that 1.1 million Canadians use cannabis for medical purposes, but more than 800,000 of them are self-medicating with recreational or illegal cannabis, without the guidance of a healthcare professional. It believes Medical Cannabis by Shoppers can redress the balance and allow Canadians to gain access to products that are safer and better suited to their medical conditions.

Shoppers uses a firm called TruTrace Technologies to run a medical cannabis strain traceability scheme that provides patients seed-to-sale information. Producers Aphria and WeedMD have signed up to partner with the retailer for the scheme, while Deloitte has also been brought in to audit the process.

A Shoppers Drug Mart Medical Advisory Board also provides pharmacists with education and guidance on clinical evidence on the effectiveness of medical cannabis. The firm has developed clinical algorithms that help its advisors select the correct strain for patients. It can also connect patients to a licensed physician or nurse practitioner to assess whether a patient is an ideal candidate for medical cannabis.
Martin Green
Martin Green

Martin Green is an experienced journalist with a strong focus on the cannabis, alcohol, and gambling industries. He is particularly interested in the political issues affecting the global marijuana trade, and he has a keen focus on regulation changes and legal topics. He holds a BA English Literature, MA Creative Writing and a National Qualification in Journalism diploma. He has worked in journalism since 2009 and written for a broad range of newspapers, business titles and magazines, including The Sun, The Metro, The Journal, Livestrong, Drinks Retailing News, Harpers, Sportsbook Review, Vital Football, Essex Live and Surrey Live.

[aries4747]

TTTSF: TruTrace Technologies Announces Second Quarter 2020 Financial and Operating Results

5:30 PM ET 12/20/19 | Dow Jones

December 20, 2019 -- (TruTrace Technologies) --

(TheNewswire)TORONTO - TheNewswire - December 20, 2019 - TruTrace Technologies Inc. (CSE:TTT) (CNSX.TTT.CN)(OTC:TTTSF) ("TruTrace" or the "Company"), creator of the first fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, today announced its financial and operating results for the three and six months ended October 31, 2019. All figures are stated in Canadian dollars.

"In the second quarter, we continued to execute on our most important priorities, highlighted by the ongoing implementation of the Shoppers Drug Mart Pilot Program and strategic alliance with Deloitte Canada, as well as the implementation of our platform with several licensed producers in the tracking of their intellectual property in their distribution of medical cannabis," said TruTrace Technologies CEO Robert Galarza. "We are very excited to become the first traceability platform in this sector to achieve these milestones with such strong partners."

Second Quarter 2020 Financial Highlights

- The Company generated revenue of $303,520 in the second quarter of fiscal 2020, compared to nil in Q2 2019 and $48,000 in Q1 2020. Revenue growth was primarily driven by implementation fees associated with the use of TruTrace technology.

- Net loss and comprehensive loss was $914,652 in the second quarter of 2020, compared to approximately $2.3 million in Q2 2019. The Company reported significantly reduced corporate development, general & administrative, salaries & benefits, and stock-based compensation expense due to efficiency initiatives and the impact of listing expenses related to the Company's reverse take-over in the prior-year period.

- Loss per share was $0.01 in Q2 2020, compared to a loss of $0.03 in Q2 2019.

- Funds used in operations totaled $707,665 in the quarter, compared to approximately $1.6 million in Q2 2019.

- Cash on hand was approximately $121,000 as at October 31, 2019, compared to approximately $1.2 million at April 30, 2019.

Operating Highlights

- Completed Phases 1 and 2 of the Shoppers Drug Mart ("Shoppers") medical cannabis verification pilot program (the "Pilot Program"), which is intended to increase transparency, interoperability, and product identification within the medical cannabis industry. The Pilot Program uses TruTrace's StrainSecure(TM) technology as a central hub for identity management, asset tracking, validation, and product authentication. StrainSecure will also serve as a master registry for standardized testing, product verification and quality assurance.

- Licensed producers (LPs) participating in the Pilot Program include: Aphria Inc., Aurora Cannabis Inc., The Flowr Corporation, Tilray Canada Ltd., United Greeneries (a subsidiary of Harvest One Cannabis Inc.), WeedMD Inc. and Zenabis Global, Inc.

- The Company added several partners to the StrainSecure ecosystem to contribute to the successful implementation of the platform, including cannabis testing lab Anandia, agricultural technology company Segra International Corp., testing and analytical services company Sigma Analytical, and clinical research and telemedicine platform AdvancedCare.

- Deloitte and TruTrace announced a strategic alliance to deliver blockchain product-traceability solutions to the cannabis industry. The Company expects the strategic alliance to lead to additional business development opportunities.

- During the second quarter, the Company completed several non-brokered private placement financings of common shares and convertibles debentures, raising total net proceeds of approximately $967,000.

Subsequent Events

- TruTrace and other Pilot Program participants continue to work towards full production and implementation of the Company's StrainSecure platform, and advancing the Pilot Program beyond its initial scope.

- In November 2019, TruTrace announced that Colombia-based multinational cannabis producer Clever Leaves has joined the StrainSecure platform in order to bring standardization and product validation into its international distribution strategy.

Outlook

"The Shoppers Pilot Program has provided a unique opportunity to validate the effectiveness of our StrainSecure platform, with the support of cornerstone clients and partners," said Robert Galarza. "Demonstrating the functionality and benefits of a new technology under real-world conditions is a vital step on the way to more widespread adoption. We expect to continue to execute on key deliverables in the coming months as the Pilot Program progresses towards full implementation."

With the launch of its StrainSecure(TM) platform, TruTrace offers an easily-integrated blockchain solution that tracks cannabis from Genome to Sale(TM) through the supply chain and provides actionable quality assurance and real-time testing data to the cannabis industry.

The Company's goal is to build a framework for licensed producers as well as micro cultivators that are entering the newly legalized ecosystem, helping them to easily and inexpensively move their products through testing procedures. TruTrace then places that testing data on the blockchain for immutability and intellectual property protection, and feed that information through the ecosystem for full visibility into the supply chain. The resulting outcome is a trustworthy source of product and inventory data that can be used to support anything from clinical trials to medical efficacy studies, as well as providing regulators, medical practitioners, patients, and even retail consumers a much-desired level of actionable intelligence. With TruTrace, all parties can see whether a product is clean, safe, pesticide-free, and truly is what it claims to be.

More detailed financial information and analysis with respect to TruTrace's results of operations are available in its unaudited financial statements and management's discussion and analysis for the period ended October 31, 2019, both of which can be found on SEDAR atwww.sedar.com.

About TruTrace Technologies:

TruTrace Technologies has developed the first integrated blockchain platform to register and track intellectual property in the cannabis industry. TruTrace's technology allows cannabis growers and breeders to identify and secure rights to their intellectual property. It also streamlines the administrative process and reduces the costs of genetic and mandatory quality-control testing for legal cannabis. TruTrace's technology is proprietary, immutable and cryptographically secure, thereby establishing an accurate and permanent account for cannabis strains from ownership to market.

For More Information:

Robert Galarza, Chief Executive Officer and Director, 844-656-3629. Investor Inquiries: Swapan Kakumanu, Chief Financial Officer, 844-656-3629, [e-mail]

Disclaimer for Forward-Looking Information

This news release includes forward-looking information within the meaning of Canadian securities legislation, concerning the business of TruTrace, including statements regarding: the intention that the Pilot Program willincrease transparency, interoperability, and product identification within the medical cannabis industry; that the addition of several partners to the StrainSecure ecosystem is expected to contribute to the successful implementation of its platform;that full production and implementation of TruTrace's StrainSecure platform are proceeding; the expectation that the strategic alliance with Deloitte to lead to additional business development opportunities; and the expectation that demonstrating the functionality and benefits of StrainSecure under real-world conditions will lead to more widespread adoption.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that it will prove to be correct and actual results and future events could differ materially from those anticipated in such information. Forward-looking information necessarily involves known and unknown risks, including, without limitation, risks associated with: general economic conditions; adverse industry events; loss of markets; future legislative and regulatory developments in Canada, the United States, and elsewhere; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; and other risks beyond the Company's control. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties and other factors, many of which are beyond the control of the Company. Readers are cautioned not to place undue reliance on any forward-looking information contained in this news release. Forward-looking information contained in this news release is provided as of the date of this news release. The Company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

Copyright (c) 2019 TheNewswire - All rights reserved.

> Dow Jones Newswires

December 20, 2019 17:30 ET (22:30 GMT)

PLEASE READ THE IMPORTANT DISCLOSURES BELOW.

[Bute]

Some positive news sure would be nice. I wonder if Phase 2 is almost completed?

[garrettf]

Small post today about rob talking at the CBD Expo on a panel:

https://www.marketscreener.com/BLOCKSTRAIN-TECHNOLOGY-CO-49479330/news/TruTrace-Technologies-to-Present-at-CBD-Expo-WEST-conference-in-San-Diego-29685215/

[Bute]

As the buy's go up, the PPS goes down. Something is wrong with this picture. Is this a joke or what? We hear nothing from management, not even a Howdy-doo.